Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Rhea-AI Summary

Avid Bioservices (NASDAQ:CDMO, CDMOP) announced participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum, taking place on March 23-24, 2021. CEO Nick Green will feature in a fireside chat on March 24 at 4:15 PM Eastern. The forum will be held virtually, providing a platform for Avid to showcase its commitment to high-quality biologics contract development and manufacturing services. Avid specializes in CGMP manufacturing for biopharmaceuticals, leveraging 28 years of experience in the industry.

TUSTIN, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum. Nick Green, president and chief executive officer of Avid Bioservices, will be the featured speaker in a fireside chat at the conference, which will take place March 23-24, 2021 in a virtual format.

Details of the company’s participation are as follows:

• KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
  Conference Date: March 23-24, 2021
  Fireside Chat Time/Date: 4:15 p.m. Eastern on Wednesday, March 24, 2021
  Format: Virtual Conference

About Avid Bioservices, Inc.

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 28 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

FAQ

What is Avid Bioservices' participation in the KeyBanc Capital Markets Investor Forum?

Avid Bioservices will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 23-24, 2021.

When will Avid Bioservices' fireside chat take place?

The fireside chat featuring CEO Nick Green will be held on March 24, 2021, at 4:15 PM Eastern.

What services does Avid Bioservices provide?

Avid Bioservices offers development and CGMP manufacturing services for biopharmaceuticals, including process development and regulatory support.

What is the focus of Avid Bioservices?

Avid Bioservices focuses on biologics contract development and manufacturing, especially for monoclonal antibodies and recombinant proteins.

Where can I find more information about Avid Bioservices?

More information can be found on Avid Bioservices' website at www.avidbio.com.